ZURZUVAE is the first and only
FDA-approved oral treatment
for adults with postpartum
depression (PPD).

Actor Portrayal

ZURZUVAE (zur-ZOO-vay) is a prescription medicine. Speak to your healthcare provider to see if ZURZUVAE® (zuranolone) is right for you.

ZURZUVAE is a 14-day treatment that may offer relief starting in 3 days

It’s taken for 14 days

Here’s what to keep in mind
about treatment

Get the details
Rapid relief starting
at day 3

In a clinical study, ZURZUVAE
improved symptoms at day 15,
and as fast as day 3

See the results

ZURZUVAE 50 mg was studied in women with PPD whose symptoms started in the third trimester or within 4 weeks of delivery in a 6-week trial. During the trial, patients took either ZURZUVAE or placebo for 14 days, and were followed up for another 4 weeks. Significantly greater PPD symptom improvement was demonstrated at Day 3, Day 15 (the primary endpoint), and Day 45 compared to placebo, using a standard depression rating scale.

ZURZUVAE For You logo

ZURZUVAE For You is a patient support program that
is here to help as you navigate your
ZURZUVAE treatment journey.

happy mom with sleeping baby on shoulder
happy mom with sleeping baby on shoulder
happy mom with sleeping baby on shoulder

Actor Portrayal

Stay up to date with details about ZURZUVAE